Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278(4):369–95. https://doi.org/10.1111/joim.12395.

Article  PubMed  Google Scholar 

Harsini S, Rezaei N. Autoimmune diseases. Clin Immunol. 2023, 123–244. https://doi.org/10.1016/B978-0-12-818006-8.00001-3.

TomićSremec N, Kozmar A, Sremec J, Anić B, Batinić D. Properties of Uncommon Indirect Immunofluorescence Staining Patterns Determined during Antinuclear Antibody Detection on HEp-2 Cells. J Clin Med. 2021;10(17):3866. https://doi.org/10.3390/jcm10173866.

Article  Google Scholar 

Irure-Ventura J, López-Hoyos M. The Past, Present, and Future in Antinuclear Antibodies (ANA). Diagnostics (Basel). 2022;12(3):647. https://doi.org/10.3390/diagnostics12030647.

Article  PubMed  Google Scholar 

Wei Q, Jiang Y, Xie J, et al. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases. J Clin Lab Anal. 2020;34(12):e23546. https://doi.org/10.1002/jcla.23546.

Article  PubMed  PubMed Central  Google Scholar 

Tešija Kuna A, Đerek L, Drvar V, Kozmar A, Gugo K. Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine. Biochem Med (Zagreb). 2021;31(2):020502. https://doi.org/10.11613/BM.2021.020502.

Article  PubMed  Google Scholar 

Bhakta V. Rare Antinuclear Antibody Patterns: Relevance in Routine Laboratory Reporting. J Clin Diagnostic Res. 2023;17(1). https://doi.org/10.7860/JCDR/2023/60084.17321

Chan EKL, von Mühlen CA, Fritzler MJ, et al. The International Consensus on ANA Patterns (ICAP) in 2021-The 6th Workshop and Current Perspectives [published correction appears in J Appl Lab Med. 2023 Mar 6;8(2):419. https://doi.org/10.1093/jalm/jfac013]. J Appl Lab Med. 2022;7(1):322–330. https://doi.org/10.1093/jalm/jfab140

Chan EK, Damoiseaux J, Carballo OG, et al. Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014–2015. Front Immunol. 2015;6:412. https://doi.org/10.3389/fimmu.2015.00412.

Article  PubMed  PubMed Central  Google Scholar 

Olsen NJ, Choi MY, Fritzler MJ. Emerging technologies in autoantibody testing for rheumatic diseases. Arthritis Res Ther. 2017Jul 24;19(1):172. https://doi.org/10.1186/s13075-017-1380-3.

Article  PubMed  PubMed Central  Google Scholar 

Bucukovski J, Carter JA, Striemer CC, et al. Label-free microarray-based detection of autoantibodies in human serum. J Immunol Methods. 2018;459:44–9. https://doi.org/10.1016/j.jim.2018.05.011.

Article  PubMed  Google Scholar 

Zhu H, Luo H, Yan M, Zuo X, Li QZ. Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus. Genomics Proteomics Bioinformatics. 2015;13(4):210–8. https://doi.org/10.1016/j.gpb.2015.09.001.

Article  PubMed  PubMed Central  Google Scholar 

Cha HJ, Hwang J, Lee LE, Park Y, Song JJ. The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease. PLoS ONE. 2021;16(1):e0244950. https://doi.org/10.1371/journal.pone.0244950.

Article  PubMed  PubMed Central  Google Scholar 

World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4. https://doi.org/10.1001/jama.2013.281053.

Article  Google Scholar 

von Mühlen CA, Garcia-De La Torre I, Infantino M, et al. How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative. Immunol Res. 2021;69(6):594–608. https://doi.org/10.1007/s12026-021-09233-0

Andrade LEC, Klotz W, Herold M, et al. International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I. Clin Chem Lab Med. 2018;56(10):1783–8. https://doi.org/10.1515/cclm-2018-0188.

Article  PubMed  Google Scholar 

Chhabra S, Kumar Y, Kumar M, Sharma, Bhardwaj R, Minz RW. Prevalence Of Autoantibodies to Cellular Cytoplasmic and Mitotic Antigens in Routine Antinuclear Antibody Reporting: Implementation of International Consensus on Antinuclear Antibodies Patterns Guidelines. Indian J Rheumatol 2021;16(1):83–88. https://doi.org/10.4103/injr.injr_198_20

Nanda R, Gupta P, Patel S, Shah S, Mohapatra E. Uncommon antinuclear antibody patterns as diagnostic indicators. Clin Biochem. 2021;90:28–33. https://doi.org/10.1016/j.clinbiochem.2021.01.008.

Article  PubMed  Google Scholar 

Ravikumar G, Pereira J, Gupta A. Non-Nuclear and Rare Nuclear ANA Patterns in Indirect Immunoflourescence Testing and their Clinical Associations. EJMO. 2023;7(2):180–8.

Google Scholar 

Erazo-Martínez V, Peñaloza D, Rosero J, et al. Antinuclear antibody staining patterns by indirect immunofluorescence assay observed in patients from a tertiary health center in Latin America. Revista Colombiana de Reumatología. 2023. https://doi.org/10.1016/j.rcreu.2023.05.003.

Article  Google Scholar 

Ceribelli A, Isailovic N, Gorlino C, et al. Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease. Front Immunol. 2022;13:822996. https://doi.org/10.3389/fimmu.2022.822996.

Article  PubMed  PubMed Central  Google Scholar 

Choi MY, FitzPatrick RD, Buhler K, Mahler M, Fritzler MJ. A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus. Autoimmun Rev. 2020;19(3):102463. https://doi.org/10.1016/j.autrev.2020.102463.

Article  PubMed  Google Scholar 

Kokuina E. Can Anti-Ribosomal Antibodies Improve Systemic Lupus Erythematosus Diagnosis? MEDICC Rev. 2021;23(1):90–1. https://doi.org/10.37757/MR2021.V23.N1.15.

Article  PubMed  Google Scholar 

Shi ZR, Cao CX, Tan GZ, Wang L. The association of serum anti-ribosomal P antibody with clinical and serological disorders in systemic lupus erythematosus: a systematic review and meta-analysis. Lupus. 2015;24(6):588–96. https://doi.org/10.1177/0961203314560003.

Article  PubMed  Google Scholar 

Wang Y, Luo P, Guo T, Zou L, Shi J, Chen P. Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus. Medicine. 2020May 15;99(20):e20192.

Article  PubMed  PubMed Central  Google Scholar 

Elsayed SA, Mohafez OM. Autoantibodies spectrum in lupus nephritis in a cohort of Egyptian patients: relation to disease activity and prognostic value. Egypt Rheumatol Rehabil. 2020Dec;47:1.

Article  Google Scholar 

Shang X, Ren L, Sun G, et al. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity. Immunity, Inflamm Dis. 2021Jun;9(2):407–18.

Article  Google Scholar 

Abdelnaby AY, Gawaly AM, Mohammed HA, Aboelnasr MS, Hagag RY, Elrefaey W. Assessment of systemic lupus erythematosus disease activity and lupus nephritis flare using anti-nucleosome and anti-C1q antibodies. Menoufia Med J. 2022;35(1):110–5.

Google Scholar 

Liao K, Li N, Bonin J, et al. The implication of anti-Ro60 with or without anti-Ro52 antibody in patients with systemic lupus erythematosus. Rheumatology. 2024;14:keae362.

Article  Google Scholar 

Vulsteke JB, Satoh M, Malyavantham K, Bossuyt X, De Langhe E, Mahler M. Anti-OJ autoantibodies: Rare or underdetected? Autoimmun Rev. 2019;18(7):658–64. https://doi.org/10.1016/j.autrev.2019.05.002.

Article  PubMed  Google Scholar 

Schumacher F, Zimmermann M, Kanbach M, et al. Clinical relevance of positively determined myositis antibodies in rheumatology: a retrospective monocentric analysis. Arthritis Res Ther. 2024;26(1):132. Published 2024 Jul 16. https://doi.org/10.1186/s13075-024-03368-9

Elamir AM, Farid AA, Amin ES, Hassan HA, Maged MM, Aref AA. Anti-nuclear antibody (ANA) patterns in egyptian systemic lupus erythematosus. J Egypt Soc Parasitol. 2019;49(2):451–4. https://doi.org/10.21608/jesp.2019.68190.

Article  Google Scholar 

Rigopoulou EI, Bogdanos DP. Role of autoantibodies in the clinical management of primary biliary cholangitis. World J Gastroenterol. 2023;29(12):1795–810. https://doi.org/10.3748/wjg.v29.i12.1795.

Article  PubMed  PubMed Central  Google Scholar